It says a degraded peptide may not activate GLP-1 receptors as intended, and, importantly for treatment decisions, that receiving subtherapeutic amounts can mask a person's true response profile and make a provider's adjustments unreliable
Its Not Sterile This is probably the biggest argument against splitting semaglutide pens: its not sterile
[1] Effective contraception is essential
All the authors have contributed significantly to the manuscript, per the International Committee of Medical Journal Editors criteria of authorship
Development of a formal clinical guideline, including specific dose-titration protocols, chronic kidney disease (CKD) considerations, and polypharmacy interactions, remains beyond the scope of this review and would require a dedicated systematic investigation
For those who qualify, 90% of health plans cover GLP-1 drugs for Type 2 diabetes, while just over 30% cover these drugs for obesity, according to a Pharmaceutical Strategies Group study